Overview
- 37 inspections across 37 sites are on record.
- 21 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
37
Sites
37
Observations
21
Career since
Sep 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Christopher G. Pearson, O.D. | 29 May 2026 | Human Drugs | |
| Nemours Foundation IRB #2 | 6 May 2026 | Medical Devices & Rad Health | |
| Edwin N. Lee, M.D. | 22 Apr 2026 | Human Drugs | On file |
| Nandita J. Jones, MD | 27 Mar 2026 | Human Drugs | |
| Melissa E. Elder, MD | 13 Mar 2026 | Biologics |
Sites inspected
Christopher G. Pearson, O.D.Longwood, United States1 insp.
Nemours Foundation IRB #2Jacksonville, United States1 insp.
Edwin N. Lee, M.D.Orlando, United States1 insp.
Nandita J. Jones, MDJacksonville, United States1 insp.
Melissa E. Elder, MDGainesville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicol Vargas4 shared
Emily A Baldwin2 shared
Ana P Barido2 shared
Sheri L Stephenson2 shared
Ricardo Vela1 shared
Jeanne J Thai1 shared
Richard A Lyght1 shared
Full investigator report
Get the verbatim findings behind Emily C Caldwell's 21 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site